AI for Drug Discovery Market - Global AI for Drug Discovery Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 -

Description

The AI for drug discovery market is on the verge of unprecedented growth, with projections indicating that it will skyrocket from its current valuation of approximately $1.6 billion in 2022 to an astounding $10.3 billion by 2030. The market is anticipated to experience an extraordinary CAGR of 30.5% between 2023 and 2030.

Key Market Trends

1. Cross-Industry Collaborations Fueling Growth: The AI for drug discovery market is benefiting from an increasing number of cross-industry collaborations and partnerships. These collaborations combine domain expertise with advanced AI capabilities, expediting drug candidate identification and optimization.
2. Accelerating Drug Development: AI is revolutionizing drug development by analyzing extensive datasets, predicting potential drug candidates, and optimizing research strategies. This streamlines processes, reduces time, and cuts costs in the pharmaceutical industry.
3. Software Dominates: Software offerings lead the AI for drug discovery market, providing essential algorithms, platforms, and tools that enable pharmaceutical companies and researchers to harness AI's power. These software solutions optimize drug discovery processes, resulting in significant time and cost savings.
4. Machine Learning Dominance: Machine learning (ML) holds the largest market share in AI for drug discovery due to its versatility in analyzing complex biological data, predicting drug-target interactions, and optimizing lead compounds.
5. Cardiovascular Disease Applications: AI is particularly effective in identifying novel drug candidates and optimizing treatment strategies for cardiovascular diseases, leading to its dominance in this healthcare sector.
6. Pharmaceutical and Biotechnology Companies Lead: Pharmaceutical and biotechnology companies are at the forefront of AI adoption for drug discovery, leveraging AI to streamline processes, identify drug candidates, and expedite research.
7. North America Takes the Lead: North America leads the AI for drug discovery market, driven by its robust pharmaceutical industry, high R&D investments, technological innovation, and supportive regulatory frameworks.
8. Asia Pacific Experiences Rapid Growth: Asia Pacific is expected to witness the highest CAGR in the AI for drug discovery market, driven by a thriving pharmaceutical sector, increasing R&D activities, and rising investments in AI technologies.

Key Growth Drivers

Growing Cross-Industry Collaborations and Partnerships: Increasing collaborations between pharmaceutical companies, AI technology providers, academic institutions, and research organizations are propelling market growth. These partnerships harness AI's potential in drug discovery, enhancing innovation and reducing development costs.

Cost and Time Efficiency: AI algorithms analyze vast datasets, predict drug candidates, and optimize research strategies, significantly reducing the time and financial resources required for drug development. The industry's urgency to control costs while expediting drug discovery is a key driver.

Patent Expiry: The patent expiry of multiple drugs drives the adoption of AI in drug discovery. AI efficiently identifies novel drug candidates, saving time and costs, which is crucial in maintaining a competitive edge in the race to develop new, patent-protected drugs.

Major Growth Barriers

Shortage of AI Workforce: The market faces challenges due to a shortage of skilled AI professionals in pharmaceutical research. Competition for AI experts hinders the full leverage of AI capabilities, potentially delaying drug discovery timelines.

Limited Availability of Data Sets: AI models rely on extensive, diverse, and well-curated data for accurate predictions. However, drug discovery often faces data scarcity, hindering AI algorithm development and validation.

Regional Front-runners

North America: With a robust pharmaceutical and biotechnology industry, high R&D investment, and technological innovation, North America leads the AI for drug discovery market. It hosts numerous AI startups and established players and boasts a dynamic ecosystem.

Asia Pacific: The region's thriving pharmaceutical sector, increasing R&D activities, and rising investments in AI technologies contribute to its high growth potential. Asia Pacific's large patient population and healthcare advancements further drive AI adoption in drug discovery.

Competitive Landscape Analysis

Leaders in the Global AI for Drug Discovery Space

1. IBM Watson Health
2. Benevolent AI
3. Atomwise
4. Insilico Medicine
5. Dahua Technology
6. Exscientia
7. Numerate
8. Berg Health
9. GNS Healthcare

10. TwoXAR

11. Cloud Pharmaceuticals

12. Recursion Pharmaceuticals

13. XtalPi

14. Cyclica

15. Envisagenics

16. BioXcel Therapeutics

1. Executive Summary

1.1. Global AI for Drug Discovery Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global AI for Drug Discovery Market Outlook, 2018 - 2030

3.1. Global AI for Drug Discovery Market Outlook, by Offering, Value (US$ Bn), 2018 - 2030
- 3.1.1. Key Highlights
  - 3.1.1.1. Software
  - 3.1.1.2. Services
3.2. Global AI for Drug Discovery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2030
- 3.2.1. Key Highlights
  - 3.2.1.1. Machine Learning
  - 3.2.1.2. Deep Learning
  - 3.2.1.3. Supervised Learning
  - 3.2.1.4. Reinforcement Learning
  - 3.2.1.5. Unsupervised Learning
  - 3.2.1.6. Other
3.3. Global AI for Drug Discovery Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 3.3.1. Key Highlights
  - 3.3.1.1. Immuno-oncology
  - 3.3.1.2. Neurodegenerative Diseases
  - 3.3.1.3. Cardiovascular Diseases
  - 3.3.1.4. Metabolic Diseases
  - 3.3.1.5. Other Applications
3.4. Global AI for Drug Discovery Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 3.4.1. Key Highlights Snacks
  - 3.4.1.1. Pharmaceutical & Biotechnology Companies
  - 3.4.1.2. Contract Research Organizations
  - 3.4.1.3. Research Centres and Academic & Government Institutes
3.5. Global AI for Drug Discovery Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America AI for Drug Discovery Market Outlook, 2018 - 2030

4.1. North America AI for Drug Discovery Market Outlook, by Offering, Value (US$ Bn), 2018 - 2030
- 4.1.1. Key Highlights
  - 4.1.1.1. Software
  - 4.1.1.2. Services
4.2. North America AI for Drug Discovery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2030
- 4.2.1. Key Highlights
  - 4.2.1.1. Machine Learning
  - 4.2.1.2. Deep Learning
  - 4.2.1.3. Supervised Learning
  - 4.2.1.4. Reinforcement Learning
  - 4.2.1.5. Unsupervised Learning
  - 4.2.1.6. Other
4.3. North America AI for Drug Discovery Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 4.3.1. Key Highlights
  - 4.3.1.1. Immuno-oncology
  - 4.3.1.2. Neurodegenerative Diseases
  - 4.3.1.3. Cardiovascular Diseases
  - 4.3.1.4. Metabolic Diseases
  - 4.3.1.5. Other Applications
4.4. North America AI for Drug Discovery Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 4.4.1. Key Highlights
  - 4.4.1.1. Pharmaceutical & Biotechnology Companies
  - 4.4.1.2. Contract Research Organizations
  - 4.4.1.3. Research Centres and Academic & Government Institutes
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America AI for Drug Discovery Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 4.5.1.2. U.S. AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 4.5.1.3. U.S. AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 4.5.1.4. U.S. AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 4.5.1.5. Canada AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 4.5.1.6. Canada AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 4.5.1.7. Canada AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 4.5.1.8. Canada AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe AI for Drug Discovery Market Outlook, 2018 - 2030

5.1. Europe AI for Drug Discovery Market Outlook, by Offering, Value (US$ Bn), 2018 - 2030
- 5.1.1. Key Highlights
  - 5.1.1.1. Software
  - 5.1.1.2. Services
5.2. Europe AI for Drug Discovery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2030
- 5.2.1. Key Highlights
  - 5.2.1.1. Machine Learning
  - 5.2.1.2. Deep Learning
  - 5.2.1.3. Supervised Learning
  - 5.2.1.4. Reinforcement Learning
  - 5.2.1.5. Unsupervised Learning
  - 5.2.1.6. Other
5.3. Europe AI for Drug Discovery Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 5.3.1. Key Highlights
  - 5.3.1.1. Immuno-oncology
  - 5.3.1.2. Neurodegenerative Diseases
  - 5.3.1.3. Cardiovascular Diseases
  - 5.3.1.4. Metabolic Diseases
  - 5.3.1.5. Other Applications
5.4. Europe AI for Drug Discovery Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 5.4.1. Key Highlights
  - 5.4.1.1. Pharmaceutical & Biotechnology Companies
  - 5.4.1.2. Contract Research Organizations
  - 5.4.1.3. Research Centres and Academic & Government Institutes
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe AI for Drug Discovery Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 5.5.1.2. Germany AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 5.5.1.3. Germany AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.5.1.4. Germany AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 5.5.1.5. U.K. AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 5.5.1.6. U.K. AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 5.5.1.7. U.K. AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.5.1.8. U.K. AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 5.5.1.9. France AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 5.5.1.10. France AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 5.5.1.11. France AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.5.1.12. France AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 5.5.1.13. Italy AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 5.5.1.14. Italy AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 5.5.1.15. Italy AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.5.1.16. Italy AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 5.5.1.17. Turkey AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 5.5.1.18. Turkey AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 5.5.1.19. Turkey AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.5.1.20. Turkey AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 5.5.1.21. Russia AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 5.5.1.22. Russia AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 5.5.1.23. Russia AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.5.1.24. Russia AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 5.5.1.25. Rest of Europe AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 5.5.1.26. Rest of Europe AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 5.5.1.27. Rest of Europe AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 5.5.1.28. Rest of Europe AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific AI for Drug Discovery Market Outlook, 2018 - 2030

6.1. Asia Pacific AI for Drug Discovery Market Outlook, by Offering, Value (US$ Bn), 2018 - 2030
- 6.1.1. Key Highlights
  - 6.1.1.1. Software
  - 6.1.1.2. Services
6.2. Asia Pacific AI for Drug Discovery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2030
- 6.2.1. Key Highlights
  - 6.2.1.1. Machine Learning
  - 6.2.1.2. Deep Learning
  - 6.2.1.3. Supervised Learning
  - 6.2.1.4. Reinforcement Learning
  - 6.2.1.5. Unsupervised Learning
  - 6.2.1.6. Other
6.3. Asia Pacific AI for Drug Discovery Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 6.3.1. Key Highlights
  - 6.3.1.1. Immuno-oncology
  - 6.3.1.2. Neurodegenerative Diseases
  - 6.3.1.3. Cardiovascular Diseases
  - 6.3.1.4. Metabolic Diseases
  - 6.3.1.5. Other Applications
6.4. Asia Pacific AI for Drug Discovery Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 6.4.1. Key Highlights
  - 6.4.1.1. Pharmaceutical & Biotechnology Companies
  - 6.4.1.2. Contract Research Organizations
  - 6.4.1.3. Research Centres and Academic & Government Institutes
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific AI for Drug Discovery Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 6.5.1. Key Highlights
  - 6.5.1.1. China AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 6.5.1.2. China AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 6.5.1.3. China AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.5.1.4. China AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 6.5.1.5. Japan AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 6.5.1.6. Japan AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 6.5.1.7. Japan AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.5.1.8. Japan AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 6.5.1.9. South Korea AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 6.5.1.10. South Korea AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 6.5.1.11. South Korea AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.5.1.12. South Korea AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 6.5.1.13. India AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 6.5.1.14. India AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 6.5.1.15. India AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.5.1.16. India AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 6.5.1.17. Southeast Asia AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 6.5.1.18. Southeast Asia AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 6.5.1.19. Southeast Asia AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.5.1.20. Southeast Asia AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 6.5.1.21. Rest of Asia Pacific AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 6.5.1.22. Rest of Asia Pacific AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 6.5.1.23. Rest of Asia Pacific AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 6.5.1.24. Rest of Asia Pacific AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America AI for Drug Discovery Market Outlook, 2018 - 2030

7.1. Latin America AI for Drug Discovery Market Outlook, by Offering, Value (US$ Bn), 2018 - 2030
- 7.1.1. Key Highlights
  - 7.1.1.1. Software
  - 7.1.1.2. Services
7.2. Latin America AI for Drug Discovery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2030
- 7.2.1. Key Highlights
  - 7.2.1.1. Machine Learning
  - 7.2.1.2. Deep Learning
  - 7.2.1.3. Supervised Learning
  - 7.2.1.4. Reinforcement Learning
  - 7.2.1.5. Unsupervised Learning
  - 7.2.1.6. Other
7.3. Latin America AI for Drug Discovery Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 7.3.1. Key Highlights
  - 7.3.1.1. Immuno-oncology
  - 7.3.1.2. Neurodegenerative Diseases
  - 7.3.1.3. Cardiovascular Diseases
  - 7.3.1.4. Metabolic Diseases
  - 7.3.1.5. Other Applications
7.4. Latin America AI for Drug Discovery Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 7.4.1. Key Highlights
  - 7.4.1.1. Pharmaceutical & Biotechnology Companies
  - 7.4.1.2. Contract Research Organizations
  - 7.4.1.3. Research Centres and Academic & Government Institutes
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America AI for Drug Discovery Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 7.5.1.2. Brazil AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 7.5.1.3. Brazil AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.5.1.4. Brazil AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 7.5.1.5. Mexico AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 7.5.1.6. Mexico AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 7.5.1.7. Mexico AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.5.1.8. Mexico AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 7.5.1.9. Argentina AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 7.5.1.10. Argentina AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 7.5.1.11. Argentina AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.5.1.12. Argentina AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 7.5.1.13. Rest of Latin America AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 7.5.1.14. Rest of Latin America AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 7.5.1.15. Rest of Latin America AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 7.5.1.16. Rest of Latin America AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa AI for Drug Discovery Market Outlook, 2018 - 2030

8.1. Middle East & Africa AI for Drug Discovery Market Outlook, by Offering, Value (US$ Bn), 2018 - 2030
- 8.1.1. Key Highlights
  - 8.1.1.1. Software
  - 8.1.1.2. Services
8.2. Middle East & Africa AI for Drug Discovery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2030
- 8.2.1. Key Highlights
  - 8.2.1.1. Machine Learning
  - 8.2.1.2. Deep Learning
  - 8.2.1.3. Supervised Learning
  - 8.2.1.4. Reinforcement Learning
  - 8.2.1.5. Unsupervised Learning
  - 8.2.1.6. Other
8.3. Middle East & Africa AI for Drug Discovery Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
- 8.3.1. Key Highlights
  - 8.3.1.1. Immuno-oncology
  - 8.3.1.2. Neurodegenerative Diseases
  - 8.3.1.3. Cardiovascular Diseases
  - 8.3.1.4. Metabolic Diseases
  - 8.3.1.5. Other Applications
8.4. Middle East & Africa AI for Drug Discovery Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
- 8.4.1. Key Highlights
  - 8.4.1.1. Pharmaceutical & Biotechnology Companies
  - 8.4.1.2. Contract Research Organizations
  - 8.4.1.3. Research Centres and Academic & Government Institutes
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa AI for Drug Discovery Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 8.5.1.2. GCC AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 8.5.1.3. GCC AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.5.1.4. GCC AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 8.5.1.5. South Africa AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 8.5.1.6. South Africa AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 8.5.1.7. South Africa AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.5.1.8. South Africa AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 8.5.1.9. Egypt AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 8.5.1.10. Egypt AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 8.5.1.11. Egypt AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.5.1.12. Egypt AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 8.5.1.13. Nigeria AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 8.5.1.14. Nigeria AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 8.5.1.15. Nigeria AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.5.1.16. Nigeria AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
  - 8.5.1.17. Rest of Middle East & Africa AI for Drug Discovery Market by Offering, Value (US$ Bn), 2018 - 2030
  - 8.5.1.18. Rest of Middle East & Africa AI for Drug Discovery Market, by Technology, Value (US$ Bn), 2018 - 2030
  - 8.5.1.19. Rest of Middle East & Africa AI for Drug Discovery Market, by Application, Value (US$ Bn), 2018 - 2030
  - 8.5.1.20. Rest of Middle East & Africa AI for Drug Discovery Market, by End User, Value (US$ Bn), 2018 - 2030
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs Technology Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. IBM Watson Health
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. BenevolentAI
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Atomwise
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Insilico Medicine
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Exscientia
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Numerate
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Berg Health
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. GNS Healthcare
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Business Strategies and Development
- 9.4.9. TwoXAR
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Cloud Pharmaceuticals
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
- 9.4.11. Recursion Pharmaceuticals
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Product Portfolio
  - 9.4.11.3. Financial Overview
  - 9.4.11.4. Business Strategies and Development
- 9.4.12. XtalPi
  - 9.4.12.1. Company Overview
  - 9.4.12.2. Product Portfolio
  - 9.4.12.3. Financial Overview
  - 9.4.12.4. Business Strategies and Development
- 9.4.13. Cyclica
  - 9.4.13.1. Company Overview
  - 9.4.13.2. Product Portfolio
  - 9.4.13.3. Financial Overview
  - 9.4.13.4. Business Strategies and Development
- 9.4.14. Envisagenics
  - 9.4.14.1. Company Overview
  - 9.4.14.2. Product Portfolio
  - 9.4.14.3. Financial Overview
  - 9.4.14.4. Business Strategies and Development
- 9.4.15. BioXcel Therapeutics
  - 9.4.15.1. Company Overview
  - 9.4.15.2. Product Portfolio
  - 9.4.15.3. Financial Overview
  - 9.4.15.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations